Then, we pretreated H9c2 cells with relevant inhibitors, including a P38-specific inhibitor (SP60012), a JNK-specific inhibitor (SB203580), and an ERK-specific inhibitor (PD98059) for 2 h and then exposed them to medium containing 20% CKD serum for 24 h. Here, MAPK8 is linked to chronic kidney disease.